The above chart presents the market trend analysis for medicef pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 14 transactions, with a transaction quantity of 47614 and a transaction weight of 0.
Product description
POTASSIUM CLAVULANATE WITH SILICON DIOXIDE 1 1 I P E P F O C FREE OF CHARGE VALUE FOR CUSTOMS PURPOSE POTASSIUM CLAVULANATE WITH SILICON DIOXIDE 1 1 I P E P
Expand
Product description
POTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WITH MICROCRYSTALLINE CELLULOSE 1 1 I PPOTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WI
Expand
Trade date
2026/01/22
B/L No.
5420236
Suppliers
zhuaq united laboratories co.ltd.
Buyers
medicef pharma
Product description
POTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WITH MICROCRYSTALLINE CELLULOSE 1 1 I PPOTASSIUM CLAVULANATE DILUTED POTASSIUM CLAVULANATE WITH MI
Expand
Trade date
2026/01/22
B/L No.
3157127
Suppliers
zhuaq united laboratories co.ltd.
Buyers
medicef pharma
Product description
POTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WITH SILICON DIOXIDE 1 1 I PPOTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WI
Expand
Trade date
2026/01/19
B/L No.
0047484
Suppliers
zhuaq united laboratories co.ltd.
Buyers
medicef pharma
Product description
POTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WITH MICROCRYSTALLINE CELLULOSE 1 1 I PPOTASSIUM CLAVULANATE DILUTED POTASSIUM CLAVULANATE WITH MI
Expand
Trade date
2026/01/10
B/L No.
2153165
Suppliers
zhuaq united laboratories co.ltd.
Buyers
medicef pharma
Product description
POTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WITH MICROCRYSTALLINE CELLULOSE 1 1 I PPOTASSIUM CLAVULANATE DILUTED POTASSIUM CLAVULANATE WITH MI
Expand
Trade date
2026/01/10
B/L No.
5060663
Suppliers
zhuaq united laboratories co.ltd.
Buyers
medicef pharma
Product description
POTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WITH MICROCRYSTALLINE CELLULOSE 1 1 I PPOTASSIUM CLAVULANATE DILUTED POTASSIUM CLAVULANATE WITH MI
Expand
Trade date
2026/01/10
B/L No.
8012510
Suppliers
zhuaq united laboratories co.ltd.
Buyers
medicef pharma
Product description
POTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WITH MICROCRYSTALLINE CELLULOSE 1 1 I PPOTASSIUM CLAVULANATE DILUTED POTASSIUM CLAVULANATE WITH MI
Expand
Product description
POTASSIUM CLAVULANATE WITH SILICON DIOXIDE 1 1 I P E P F O C FREE OF CHARGE VALUE FOR CUSTOMS PURPOSE POTASSIUM CLAVULANATE WITH SILICON DIOXIDE 1 1 I P E P
Expand
Product description
POTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WITH MICROCRYSTALLINE CELLULOSE 1 1 I PPOTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WI
Expand
Trade date
2025/12/20
B/L No.
6002756
Suppliers
sinobright pharmaceuticals industri
Buyers
medicef pharma
Product description
POTASSIUM CLAVULANATE DILUTED I P POTASSIUM CLAVULANATE WITH MICROCRYSTALLINE CELLULOSE 1 1 I PPOTASSIUM CLAVULANATE DILUTED POTASSIUM CLAVULANATE WITH MI
Expand
medicef pharma is india Buyer&Supplier,
and primarily engages in the import and export business of products such as potassium clavulanate,microcrystalline cellulose,silicon dioxide.
According to the 52wmb.com global trade database, as of 2026-02-24, the company has completed 3364 international trades,
with its main trading regions covering china,italy,korea etc.
The core products include HS29419090,HS30039090,HS84213920 etc,
often transported via delhi,port nhava sheva sea innsa1, port jawaharlal nehru (nhava sheva) etc,
and its main trading partners are zhuaq united laboratories co.ltd.,jiangxi imports&export co.ltd.,credit pharma co ltd.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on medicef pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.